MILAN, Italy, May 19 /PRNewswire/ -- Eurand announced today that UBS will webcast a corporate update on Tuesday, May 25, 2004 at 8:30 a.m. EDT. The presentation will be webcast live from the Grand Hyatt Hotel in New York and may be accessed under the Conferences (Global Specialty Pharmaceuticals) tab at http://www.ibb.ubs.com/. The update will be provided by Chairman and CEO Mr. Gearoid Faherty. The presentation will be archived for 30 days.
Eurand is a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug delivery technologies. The Company specializes in bioavailability enhancement of poorly soluble drugs utilizing its Biorise(R) platform, modified release and taste masking and is currently developing a pipeline of products based on its proprietary technologies. Eurand also works with many of the world's leading pharmaceutical and biotechnology companies to develop enhanced forms of their existing products and development compounds. Eurand's headquarters are located in Milan, Italy while Eurand's U.S. operating offices are in Vandalia, Ohio. The Company has research, development and manufacturing facilities in Italy, the United States and manufacturing facilities in France.
EurandCONTACT: Gearoid Faherty, CEO of Eurand, (Italy) +39-02-954281, orbizdev@eurand.com
